IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy (Q43837625)
Jump to navigation
Jump to search
scientific article published on 3 July 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy |
scientific article published on 3 July 2012 |
Statements
1 reference
IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy (English)
1 reference
Hiroaki Motegi
1 reference
Yuuta Kamoshima
1 reference
Shunsuke Terasaka
1 reference
Hiroyuki Kobayashi
1 reference
Shigeru Yamaguchi
1 reference
Mishie Tanino
1 reference
Junichi Murata
1 reference
Kiyohiro Houkin
1 reference
3 July 2012
1 reference
1 reference
30
1 reference
2
1 reference
67-72
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference